Levels of statistical significance between treatments regarding survival at 30 days, 300 days, or both
| P . | Days 30 and 300 . | Day 30 only . | Day 300 only . |
|---|---|---|---|
| < .0001 | 5F, 4F, 4Fs, and TPO > C | 4F10 > C, 3F > C | — |
| 5F and 4F > SDF-1 | |||
| < .001 | — | 5F > 3F, 5F > 4F10 | 4F10 > C |
| 4F > 4F10 | |||
| < .01 | — | 5F > TPO | 3F > C |
| 4F > 3F | 5F and 4F > SDF-1 | ||
| 4F > 4F10 | |||
| < .05 | 4Fs > SDF-1 | 5F > 4Fs, TPO > SDF-1 | 5F and 4F > 3F |
| SDF-1 > C | 5F and 4Fs > 4F10 | ||
| 4F > TPO | |||
| NS | 5F and 4Fs = 4F | 4Fs = 4F10 | 5F = 4Fs, |
| 4Fs and 4F10 = 3F | 4F10 and SDF-1 = C | ||
| 4Fs, 4F10, and 3F = TPO | TPO = SDF-1 | ||
| 4F10 and 3F = SDF-1 | 5F and 4F = TPO |
| P . | Days 30 and 300 . | Day 30 only . | Day 300 only . |
|---|---|---|---|
| < .0001 | 5F, 4F, 4Fs, and TPO > C | 4F10 > C, 3F > C | — |
| 5F and 4F > SDF-1 | |||
| < .001 | — | 5F > 3F, 5F > 4F10 | 4F10 > C |
| 4F > 4F10 | |||
| < .01 | — | 5F > TPO | 3F > C |
| 4F > 3F | 5F and 4F > SDF-1 | ||
| 4F > 4F10 | |||
| < .05 | 4Fs > SDF-1 | 5F > 4Fs, TPO > SDF-1 | 5F and 4F > 3F |
| SDF-1 > C | 5F and 4Fs > 4F10 | ||
| 4F > TPO | |||
| NS | 5F and 4Fs = 4F | 4Fs = 4F10 | 5F = 4Fs, |
| 4Fs and 4F10 = 3F | 4F10 and SDF-1 = C | ||
| 4Fs, 4F10, and 3F = TPO | TPO = SDF-1 | ||
| 4F10 and 3F = SDF-1 | 5F and 4F = TPO |
Statistical significance was determined between groups using χ2 analysis with Yates correction. 4Fs means 4Fsingle, which is 4F given only at 2 hours after TBI. Each cytokine was given at 50 μg/kg. 4F10 is 4F given at 2 hours and 24 hours after TBI. Each cytokine was given at 10 μg/kg. NS indicates not significant; —, no results.